When the body digests Omega 3 fatty acids, it produces endocannabinoid compounds that are related to compounds found in marijuana, but which lack a psychoactive effect. Endocannabinoid molecules bind to the receptors of the endocannabinoid system, and can have potent anti-inflammatory, painkilling and anti-cancer effects. Clinical studies with mice suggest that some of these compounds can slow the growth of osteosarcoma cells, or even kill them. Specifically, the endocannabinoids inhibit growth of new blood vessels. Further research may reveal possible applications for concentrated endocannabinoids in cancer treatment.
- Endocannabinoids, which bond to receptors in the Endocannabinoid system, help to fight pain, inflammation, and possibly cancer cell growth.
- Preliminary research suggests that endocannabinoids may inhibit the growth of blood vessels in osteosarcoma cancer cells.
- While the endocannabinoid compounds seem to have promise, a clinical setting would usually require a highly concentrated and purified form of it.
“A class of molecules formed when the body metabolizes omega-3 fatty acids could inhibit cancer’s growth and spread, University of Illinois researchers report in a new study in mice.”